-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905A.O3.6 905. Outcomes Research – Lymphoid Malignancies: Practice Changing Patient-Reported Outcome Measurements and Real World Evidence Studies in Patients With Lymphoma

Symposia: Outcomes Research—Lymphoid Malignancies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Lymphomas, Clinical Research, health outcomes research, health disparities research, Diversity, Equity, and Inclusion (DEI) , patient-reported outcomes, Diseases, real-world evidence, Lymphoid Malignancies, Adverse Events, survivorship
Saturday, December 9, 2023: 4:00 PM-5:30 PM
Hall A (San Diego Convention Center)
Moderators:
Hira Mian, MD, McMaster University and Patrick Connor Johnson, MD, Massachusetts General Hospital
Disclosures:
Johnson: Seagen: Consultancy; AstraZeneca: Consultancy, Research Funding; ADC Therapeutics: Consultancy; Incyte: Consultancy, Research Funding; Abbvie: Consultancy; Medically Home: Research Funding; Bristol Myers Squibb: Consultancy.
In this session we will see practice changing after Patient-Reported Outcome Measurements (PROMs) and Real World Evidence (RWE) studies in patients with lymphoma. Disparities and comorbidities such as cardiovascular diseases may have a worse outcome in patients with lymphoma. 
4:00 PM

Gin Yi Lee1*, Clare Huang2* and Kevin Sheng-Kai Ma2,3,4*

1Brigham and Women`s Hospital, BOSTON, MA
2Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA
3Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA
4Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

4:15 PM

Narendranath Epperla, MD, MS1, Jeffrey M. Switchenko, PhD, MS2*, Susan M. Geyer, PhD3, Veronika Bachanova, MD, PhD4, Stefan K. Barta, MD5, Alexey Danilov, MD6, Natalie S. Grover, MD7, Reem Karmali, MD, MSc8, Brian T. Hill, MD9, Nilanjan Ghosh, MD, PhD10, Timothy S. Fenske, MD11*, Peter Martin, MD12, Brad S. Kahl, MD13, Christopher R. Flowers, MD, MS14, Brian K. Link, MD15*, Eric D. Hsi, MD16, Kami J. Maddocks, MD17, Kristie A. Blum, MD18, Thomas M. Habermann, MD19, Matthew J. Maurer, DSc20, Lawrence David Kaplan, MD21, Nancy L. Bartlett, MD22, John P. Leonard23 and Jonathon B. Cohen, MD, MS24

1The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
2Emory University, Atlanta, GA
3Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN
4Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
5Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
6Department of Hematology and HCT, City of Hope National Medical Center, La Canada Flintridge, CA
7Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
8Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
9Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
10Levine Cancer Institute/Atrium Health, Charlotte, NC
11Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
12Weill Cornell Medical College, New York, NY
13Siteman Cancer Center, Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
14Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
15Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
16Department of Pathology, Wake Forest Baptist Medical Center, Winston Salem, NC
17The Ohio State University Comprehensive Cancer Center, Columbus, OH
18Winship Cancer Institute of Emory University, Atlanta, GA
19Division of Hematology, Mayo Clinic, Rochester, MN
20Department of Health Sciences Research, Mayo Clinic, Rochester, MN
21University of California, San Francisco, CA
22Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
23Weill Cornell Medicine, New York, NY
24Winship Cancer Institute, Emory University, Atlanta, GA

4:30 PM

Niloufer Khan, MD1, Esther Drill, DrPH2*, Alison Moskowitz, MD3, Michi M Shinohara, MD4*, Cecilia Larocca, MD5*, Christiane Querfeld, MD, PhD6, Jasmine M. Zain, MD1 and Steven M. Horwitz, MD3

1Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
2Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
3Memorial Sloan Kettering Cancer Center, New York, NY
4Division of Dermatology, University of Washington, Seattle, WA
5Brigham Women's and Children's Hospital, Boston, MA
6City of Hope, Duarte, CA

4:45 PM

Kaitlin Annunzio, DO1, Eric McLaughlin, MS2*, Timothy Voorhees, MD, MSCR3, Lauren Kelly Shea, MD, MS4, Nuttavut Sumransub, MD5, Ashley Rose, MD6, Adam J Olszewski, MD7, Neil Bailey, MSc8*, Krish Patel8*, Tamara K. Moyo, MD9*, Farrukh T. Awan, MD10, Gulrayz Ahmed, MD, FACP11, Natalie S. Grover, MD12, Adam Adika, MD13*, Erica L Andres, MD14*, Muhammad Salman Faisal15*, Beth Christian, MD1, Jacob Anna16*, Steven M. Bair, MD17, Nicholas Kendsersky, MD18, Colin Thomas, MD18, Pallawi Torka, MD19, Jakub Svoboda, MD20, Jordan S Carter, MD13, Mehdi Hamadani, MD11, Hayder Saeed, MD6, Sanjal H. Desai, MBBS21, Andrew M Evens, DO, MBA, MMSc22 and Narendranath Epperla, MD, MS23

1The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
2Center for Biostatistics, The Ohio State University, Columbus, OH
3Department of Hematology, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
4O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
5Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
6H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
7Brown University, Providence, RI
8Swedish Cancer Institute, Seattle, WA
9Atrium Health / Levine Cancer Institute, Charlotte, NC
10University of Texas Southwestern Medical Center, Dallas
11Medical College of Wisconsin, Milwaukee, WI
12Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
13Temple University Hospital, Philadelphia, PA
14University of Pennsylvania, Philadelphia, PA
15Roswell Park Cancer Center, Buffalo, NewYork, Buffalo, NY
16University of Colorado, Aurora, CO
17Division of Hematology, University of Colorado - Anschutz Medical Campus, Aurora, CO
18Thomas Jefferson University Hospital, Philadelphia, PA
19Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
20Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
21University of Minnesota, Saint Paul, MN
22Division of Blood Disorders, Rutgers Cancer Institute New Jersey, New Brunswick, NJ
23The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH

5:00 PM

Jorge A Florindez, MD1, Dai Chihara, MD, PhD2, Isildinha M. Reis, PhD3*, Izidore S. Lossos, MD4 and Juan Pablo Alderuccio, MD5,6

1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
2The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Public Health Sciences and Biostatistics and Bioinformatics Shared Resource, University of Miami Miller School of Medicine, Miami, FL
4University of Miami - Miller School of Medicine, Miami, FL
5Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
6Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami School of Medicine, Miami, FL

5:15 PM

Mustafa Wasifuddin, MD1*, Nosakhare Paul Ilerhunmwuwa, MBBS, MSc1, Henry Becerra, MD1*, Ifeanyi Nnamdi Uche, MBBS1, Narek Hakobyan1*, Jin Zheng2*, Ruchi Yadav, MD2*, Boris Avezbakiyev, MD3* and Jen-Chin Wang, MD4

1Department of Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY
2Division of Hematology/Oncology, Brookdale University Hospital and Medical Center, Brooklyn, NY
3Brookdale Hospital, Middle Village, NY
4Division of Hematology/Oncology, Brookdale University Hospital and Medical Center, Long Beach, NY

*signifies non-member of ASH